{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:47:46Z","timestamp":1792219666921,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.cbi.2020.109296","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T03:52:17Z","timestamp":1603165937000},"page":"109296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Targeting intracellular Leishmania (L.) infantum with nitazoxanide entrapped into phosphatidylserine-nanoliposomes: An experimental study"],"prefix":"10.1016","volume":"332","author":[{"given":"Erika Gracielle","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro R.S.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato A.","family":"Mortara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre Gustavo","family":"Tempone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2020.109296_bib1","series-title":"Visceral Leishmaniasis","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.cbi.2020.109296_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00281-020-00788-y","article-title":"Leishmaniasis immunopathology-impact on design and use of vaccines, diagnostics and drugs","volume":"42","author":"Kaye","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.cbi.2020.109296_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2217\/17460913.2.6.583","article-title":"Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent","volume":"2","author":"Aslam","year":"2007","journal-title":"Future Microbiol."},{"issue":"3","key":"10.1016\/j.cbi.2020.109296_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3390\/cancers5031163","article-title":"Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose?","volume":"5","author":"Di Santo","year":"2013","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2020.109296_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.cbi.2020.109296_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s13063-020-04448-2","article-title":"Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Calder\u00f3n","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.cbi.2020.109296_bib7","doi-asserted-by":"crossref","first-page":"104874","DOI":"10.1016\/j.phrs.2020.104874","article-title":"Nitazoxanide\/azithromycin combination for COVID-19: a suggested new protocol for early management","volume":"157","author":"Kelleni","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.cbi.2020.109296_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/AAC.03947-14","article-title":"Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro","volume":"59","author":"Belardo","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.cbi.2020.109296_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(14)70717-0","article-title":"US Nitazoxanide Influenza Clinical Study Group. Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b\/3 trial","volume":"14","author":"Haffizulla","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.cbi.2020.109296_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/aid.2014.0015","article-title":"Nitazoxanide inhibits HIV viral replication in monocyte-derived macrophages","volume":"31","author":"Gekonge","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"1","key":"10.1016\/j.cbi.2020.109296_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2013.12.002","article-title":"Nitazoxanide: nematicidal mode of action and drug combination studies","volume":"193","author":"Somvanshi","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.cbi.2020.109296_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00436-010-1906-y","article-title":"In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani","volume":"107","author":"Zhang","year":"2010","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cbi.2020.109296_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejps.2017.10.038","article-title":"Laser-responsive liposome for selective tumor targeting of nitazoxanide nanoparticles","volume":"111","author":"Darwish","year":"2018","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2020.109296_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cbi.2015.08.023","article-title":"Co-encapsulation of chrysophsin-1 and epirubicin in PEGylated liposomes circumvents multidrug resistance in HeLa cells","volume":"242","author":"Lo","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.cbi.2020.109296_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006988","article-title":"A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia","volume":"13","author":"Diro","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.cbi.2020.109296_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jsps.2012.03.005","article-title":"Loss of orally administered drugs in GI tract","volume":"20","author":"Gavhane","year":"2012","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.cbi.2020.109296_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1461-5347(00)00255-8","article-title":"Therapeutic applications of colloidal drug carriers","volume":"3","author":"Barratt","year":"2000","journal-title":"Pharmaceut. Sci. Technol. Today"},{"issue":"1","key":"10.1016\/j.cbi.2020.109296_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/1556-276X-6-482","article-title":"Nanoliposomes for encapsulation and delivery of the potential antitumoral methyl 6-methoxy-3-(4 methoxyphenyl)-1Hindole-2-carboxylate","volume":"6","author":"Abreu","year":"2011","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.cbi.2020.109296_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-5173(97)00135-X","article-title":"U.S. Sharma, Liposomes in drug delivery: progress and limitations","volume":"154","author":"Sharma","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2020.109296_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jac\/dkh281","article-title":"Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine","volume":"54","author":"Tempone","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cbi.2020.109296_bib21","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1016\/S0021-9258(19)34110-9","article-title":"Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages","volume":"265","author":"Nishikawa","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2020.109296_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0049-3848(99)00179-6","article-title":"PS-liposome and ox-LDL bind to different sites of the immunodominant domain (#155-183) of CD36: a study with GS95, a new anti-CD36 monoclonal antibody","volume":"97","author":"Yamaguchi","year":"2000","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cbi.2020.109296_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-1759(86)90183-3","article-title":"An improved colorimetric assay for interleukin 2","volume":"93","author":"Tada","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cbi.2020.109296_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2736(80)90406-X","article-title":"Fluorescence studies on the mechanism of liposome-cell interactions in vitro","volume":"600","author":"Szoka","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.cbi.2020.109296_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0250-474X.89763","article-title":"RP-HPLC method for simultaneous estimation of nitazoxanide and ofloxacin in tablets","volume":"73","author":"Sharma","year":"2011","journal-title":"Indian J. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2020.109296_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fcimb.2019.00353","article-title":"Sertraline delivered in phosphatidylserine liposomes is effective in an experimental model of visceral leishmaniasis","volume":"9","author":"Romanelli","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cbi.2020.109296_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijantimicag.2010.04.006","article-title":"Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis","volume":"36","author":"Tempone","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.cbi.2020.109296_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exppara.2011.02.021","article-title":"In vitro and experimental therapeutic studies of the calcium channel blocker bepridil: detection of viable Leishmania (L.) chagasi by real-time PCR","volume":"128","author":"Reim\u00e3o","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cbi.2020.109296_bib29","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.bbamem.2013.06.009","article-title":"rBPI21 interacts with negative membranes endothermically promoting the formation of rigid multilamellar structures","volume":"1828m","author":"Domingues","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2020.109296_bib30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbamem.2007.12.005","article-title":"Lamy Influence of salt on the structure of DMPG studied by SAXS and optical microscopy","volume":"1778","author":"Fernandez","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2020.109296_bib31","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/jac\/dkp117","article-title":"Nitazoxanide, tizoxanide and a new analogue [4-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide; NTB] inhibit the growth of kinetoplastid parasites (Trypanosoma cruzi and Leishmania mexicana) in vitro","volume":"63","author":"Chan-Bacab","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cbi.2020.109296_bib32","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.actatropica.2013.09.018","article-title":"Lethal action of the nitrothiazolyl-salicylamide derivative nitazoxanide via induction of oxidative stress in Leishmania (L.) infantum","volume":"128","author":"Mesquita","year":"2013","journal-title":"Acta Trop."},{"key":"10.1016\/j.cbi.2020.109296_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/clinids\/19.2.362","article-title":"Visceral leishmaniasis following treatment with liposomal amphotericin B","volume":"19","author":"McBride","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cbi.2020.109296_bib34","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.biopha.2018.05.004","article-title":"Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: a candidate formulation for visceral leishmaniasis","volume":"103","author":"Borborema","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2020.109296_bib35","doi-asserted-by":"crossref","first-page":"16221","DOI":"10.1074\/jbc.270.27.16221","article-title":"The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids","volume":"270","author":"Rigotti","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2020.109296_bib36","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3855\/jidc.8022","article-title":"A highly sensitive Leishmania infantum chagasi isolation method from bone marrow and peripheral blood of adults and children","volume":"24","author":"Suzuki","year":"2016","journal-title":"J. Infect. Dev. Ctries"},{"key":"10.1016\/j.cbi.2020.109296_bib37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/excr.1996.0030","article-title":"SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells","volume":"10","author":"Fukasawa","year":"1996","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cbi.2020.109296_bib38","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1194\/jlr.M800405-JLR200","article-title":"Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis","volume":"50","author":"Maiseyeu","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cbi.2020.109296_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijantimicag.2010.04.006","article-title":"Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis","volume":"36","author":"Tempone","year":"2010","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279720315325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279720315325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:00:54Z","timestamp":1757858454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279720315325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":39,"alternative-id":["S0009279720315325"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109296","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting intracellular Leishmania (L.) infantum with nitazoxanide entrapped into phosphatidylserine-nanoliposomes: An experimental study","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109296"}}